Back to results
US 2022/0275337 A1Published application
Cellular compositions comprising viral vectors and methods of treatment
AssigneeMesoblast International Sarl
InventorsDan DEVINE, Nick LOIZOS, Silviu ITESCU
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to cellular compositions that are modified to introduce a recombinant virus. Such compositions may be used to treat cancer by delivering vims to cancer cells.
Claims33
A population of mesenchymal lineage precursor or stem cells, wherein said cells are modified to increase expression of Phosphatase and Tensin Homolog deleted on chromosome 10 alpha (PTENα).
The population of claim 5, wherein the recombinant virus is an oncolytic virus. The population of claim 5 or claim 6, wherein the virus comprises a herpes simplex virus (HSV) backbone.
Dependencies are inferred from the claim text.